187 related articles for article (PubMed ID: 16607011)
1. Conserved fungal genes as potential targets for broad-spectrum antifungal drug discovery.
Liu M; Healy MD; Dougherty BA; Esposito KM; Maurice TC; Mazzucco CE; Bruccoleri RE; Davison DB; Frosco M; Barrett JF; Wang YK
Eukaryot Cell; 2006 Apr; 5(4):638-49. PubMed ID: 16607011
[TBL] [Abstract][Full Text] [Related]
2. Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery.
Roemer T; Jiang B; Davison J; Ketela T; Veillette K; Breton A; Tandia F; Linteau A; Sillaots S; Marta C; Martel N; Veronneau S; Lemieux S; Kauffman S; Becker J; Storms R; Boone C; Bussey H
Mol Microbiol; 2003 Oct; 50(1):167-81. PubMed ID: 14507372
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of the Candida albicans Phosphopantetheinyl Transferase Ppt2 as a Potential Antifungal Drug Target.
Dobb KS; Kaye SJ; Beckmann N; Thain JL; Stateva L; Birch M; Oliver JD
PLoS One; 2015; 10(11):e0143770. PubMed ID: 26606674
[TBL] [Abstract][Full Text] [Related]
4. An antisense-based functional genomics approach for identification of genes critical for growth of Candida albicans.
De Backer MD; Nelissen B; Logghe M; Viaene J; Loonen I; Vandoninck S; de Hoogt R; Dewaele S; Simons FA; Verhasselt P; Vanhoof G; Contreras R; Luyten WH
Nat Biotechnol; 2001 Mar; 19(3):235-41. PubMed ID: 11231556
[TBL] [Abstract][Full Text] [Related]
5. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.
Sanglard D; Ischer F; Monod M; Bille J
Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():405-416. PubMed ID: 9043118
[TBL] [Abstract][Full Text] [Related]
6. An automated high-throughput cell-based multiplexed flow cytometry assay to identify novel compounds to target Candida albicans virulence-related proteins.
Bernardo SM; Allen CP; Waller A; Young SM; Oprea T; Sklar LA; Lee SA
PLoS One; 2014; 9(10):e110354. PubMed ID: 25350399
[TBL] [Abstract][Full Text] [Related]
7. Integrated antifungal drug discovery in Candida albicans.
Sanglard D
Nat Biotechnol; 2001 Mar; 19(3):212-3. PubMed ID: 11231545
[No Abstract] [Full Text] [Related]
8. SRE1 and SRE2 are two specific steroid-responsive modules of Candida drug resistance gene 1 (CDR1) promoter.
Karnani N; Gaur NA; Jha S; Puri N; Krishnamurthy S; Goswami SK; Mukhopadhyay G; Prasad R
Yeast; 2004 Feb; 21(3):219-39. PubMed ID: 14968428
[TBL] [Abstract][Full Text] [Related]
9. Candida albicans sterol C-14 reductase, encoded by the ERG24 gene, as a potential antifungal target site.
Jia N; Arthington-Skaggs B; Lee W; Pierson CA; Lees ND; Eckstein J; Barbuch R; Bard M
Antimicrob Agents Chemother; 2002 Apr; 46(4):947-57. PubMed ID: 11897574
[TBL] [Abstract][Full Text] [Related]
10. Gene Essentiality Analyzed by
Segal ES; Gritsenko V; Levitan A; Yadav B; Dror N; Steenwyk JL; Silberberg Y; Mielich K; Rokas A; Gow NAR; Kunze R; Sharan R; Berman J
mBio; 2018 Oct; 9(5):. PubMed ID: 30377286
[TBL] [Abstract][Full Text] [Related]
11. Genomic identification of potential targets unique to Candida albicans for the discovery of antifungal agents.
Tripathi H; Luqman S; Meena A; Khan F
Curr Drug Targets; 2014 Jan; 15(1):136-49. PubMed ID: 24102473
[TBL] [Abstract][Full Text] [Related]
12. Pathway analysis of Candida albicans survival and virulence determinants in a murine infection model.
Becker JM; Kauffman SJ; Hauser M; Huang L; Lin M; Sillaots S; Jiang B; Xu D; Roemer T
Proc Natl Acad Sci U S A; 2010 Dec; 107(51):22044-9. PubMed ID: 21135205
[TBL] [Abstract][Full Text] [Related]
13. Discovery of cercosporamide, a known antifungal natural product, as a selective Pkc1 kinase inhibitor through high-throughput screening.
Sussman A; Huss K; Chio LC; Heidler S; Shaw M; Ma D; Zhu G; Campbell RM; Park TS; Kulanthaivel P; Scott JE; Carpenter JW; Strege MA; Belvo MD; Swartling JR; Fischl A; Yeh WK; Shih C; Ye XS
Eukaryot Cell; 2004 Aug; 3(4):932-43. PubMed ID: 15302826
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation.
Smith WL; Edlind TD
Antimicrob Agents Chemother; 2002 Nov; 46(11):3532-9. PubMed ID: 12384361
[TBL] [Abstract][Full Text] [Related]
15. Genomics strategies for antifungal drug discovery--from gene discovery to compound screening.
Willins DA; Kessler M; Walker SS; Reyes GR; Cottarel G
Curr Pharm Des; 2002; 8(13):1137-54. PubMed ID: 12052224
[TBL] [Abstract][Full Text] [Related]
16. Sequencing, disruption, and characterization of the Candida albicans sterol methyltransferase (ERG6) gene: drug susceptibility studies in erg6 mutants.
Jensen-Pergakes KL; Kennedy MA; Lees ND; Barbuch R; Koegel C; Bard M
Antimicrob Agents Chemother; 1998 May; 42(5):1160-7. PubMed ID: 9593144
[TBL] [Abstract][Full Text] [Related]
17. Promising Antifungal Targets Against
Li Y; Sun L; Lu C; Gong Y; Li M; Sun S
Front Cell Infect Microbiol; 2018; 8():286. PubMed ID: 30234023
[TBL] [Abstract][Full Text] [Related]
18. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors.
Sanglard D; Ischer F; Monod M; Bille J
Antimicrob Agents Chemother; 1996 Oct; 40(10):2300-5. PubMed ID: 8891134
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Candida albicans growth by brominated furanones.
Duo M; Zhang M; Luk YY; Ren D
Appl Microbiol Biotechnol; 2010 Feb; 85(5):1551-63. PubMed ID: 19756586
[TBL] [Abstract][Full Text] [Related]
20. Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes.
MacPherson S; Akache B; Weber S; De Deken X; Raymond M; Turcotte B
Antimicrob Agents Chemother; 2005 May; 49(5):1745-52. PubMed ID: 15855491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
